From insulin to Ozempic, history of Novo Nordisk's CEOs:
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company ...
reuters.com/sustainability/boards-policy-regulation/insulin-ozempic-history-novo-nordisks-ceos-2025-05-16/
Photo: reuters.com · view article
Novo Nordisk CEO Ousted Amid Obesity Drug RivalryCEO Jorgensen was removed in May 2024 as Novo Nordisk faces strong competition in obesity treatments from Eli Lilly.
- Novo Nordisk dismissed CEO Lars Fruergaard Jorgensen on May 16, 2024, due to declining market leadership in obesity drugs.
- The company has had five CEOs over its century-long history, with Jorgensen serving the shortest term.
- During his tenure, Ozempic was approved in 2017 for diabetes and Wegovy in 2021 for obesity treatment.
- Novo’s next-generation obesity drug underperformed in late 2024 trials, weakening its position against Eli Lilly’s Zepbound.
I did not see the decision coming and was only informed very recently.— Lars Fruergaard Jorgensen in an interview with Danish broadcaster TV2 about his ousting as CEO of Novo Nordisk.
Story Details
| Last Updated | |
| Total Articles | 44 |
Main Topics
News on this topic
Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
abc.net.au/news/2025-05-17/novo-nordisk-ozempic-ceo-lars-fruergaard-jorgensen-resigns/105304102
From insulin to Ozempic, history of Novo Nordisk's CEOs: Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company ...
reuters.com/sustainability/boards-policy-regulation/insulin-ozempic-history-novo-nordisks-ceos-2025-05-16/
Novo Nordisk CEO to step down as Wegovy maker faces growing competition: The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for ...
cnbc.com/2025/05/16/novo-nordisk-ceo-to-step-down-as-competition-weighs-on-share-price.html
More articles on this subject
Previous
Novo Nordisk announces CEO transition as share price slips: Longtime CEO Lars Fruergaard Jørgensen to support transition while board searches for successor.
fastcompany.com/91336177/novo-nordisk-announces-ceo-transition-as-share-price-slips
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
thehill.com/homenews/ap/ap-business/ap-ceo-of-novo-nordisk-maker-of-weight-loss-drug-wegovy-to-step-down-in-wake-of-share-price-drop/
In surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging sales: Days earlier, Novo Nordisk cut its sales and profit forecast for first time since the ...
aljazeera.com/economy/2025/5/16/in-surprise-move-wegovy-maker-novo-nordisk-ousts-ceo-amid-sagging-sales
Novo Nordisk ousts CEO after falling behind in weight loss market: Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the ...
reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-ceo-step-down-2025-05-16/
Novo Nordisk CEO steps down amid growing competition for weight loss drugs: Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017 ...
euronews.com/health/2025/05/16/novo-nordisk-ceo-steps-down-amid-growing-competition-for-weight-loss-drugs
Pharmaceutical industry: CEO of Novo Nordisk resigns: Change of leadership at Novo Nordisk: Lars Fruergaard Jorgensen gives up his position at the Danish ...
wiwo.de/unternehmen/industrie/pharmaindustrie-chef-von-novo-nordisk-tritt-zurueck/100128880.html
Novo Nordisk: CEO leaves, forecast confirmed - | what the analysts say: Novo Nordisk confirms annual targets despite CEO resignation; share recovers after ...
deraktionaer.de/artikel/aktien/novo-nordisk-chef-geht-prognose-bestaetigt-das-sagen-die-analysten-20380313.html
Ozempic maker’s CEO, Lars Jørgensen, steps down after ‘compounders’ took a part of their business
financialexpress.com/business/healthcare-ozempic-makers-ceo-lars-jrgensen-steps-down-after-stock-dropped-50-in-a-year-3847522/
Novo Nordisk CEO steps down as Wegovy maker faces increased competition: As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down ...
foxbusiness.com/lifestyle/novo-nordisk-ceo-stepping-down-rivals-catch-up-weight-loss-space
Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down
cbsnews.com/news/novo-nordisk-ceo-lars-jorgensen-weight-loss-drug-wegovy-to-step-down/
Novo Nordisk ousts CEO after falling behind in weight loss market: COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...
finance.yahoo.com/news/obesity-drug-maker-novo-nordisks-110651339.html
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
apnews.com/article/wegovy-zepbound-obesity-novo-nordisk-eli-lilly-f725a97267e34781ea8dfafa3f82ae5c
Novo Nordisk CEO steps down amid tough weight loss market: "The changes are made in light of the recent market challenges Novo Nordisk has been facing ...
euractiv.com/section/health-consumers/news/novo-nordisk-ceo-steps-down-amid-tough-weight-loss-market/
Wegovy maker Novo Nordisk CEO to step down: Novo has faced challenges developing next-generation obesity drugs and seen its share price plummet.
axios.com/2025/05/16/wegovy-maker-ceo-to-step-down
Boss of Ozempic-maker Novo Nordisk steps down: Diabetes and obesity drug manufacturer saw its share price tumble in the past year.
politico.eu/article/novo-nordisk-boss-steps-down/
BREAKING: Novo Nordisk CEO resigns: Novo Nordisk CEO Lars Fruergaard Jørgensen resigns; share price falls.
deraktionaer.de/artikel/aktien/breaking-novo-nordisk-chef-tritt-zurueck-20380310.html
Pharma: Novo Nordisk CEO Jorgensen resigns after share price slump: The CEO of the Danish pharmaceutical company is leaving due to the decline in its share price ...
handelsblatt.com/unternehmen/industrie/pharma-novo-nordisk-chef-jorgensen-tritt-nach-kursrutsch-zurueck/100128867.html
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
bostonherald.com/2025/05/16/ceo-novo-nordisk-steps-down/
The Globe and Mail May 16
Obesity drug maker Novo Nordisk ousts CEO as competition weighs: Jorgensen, who has been CEO since 2017, will remain in the role until a new CEO has been ...
theglobeandmail.com/business/international-business/article-obesity-drug-maker-novo-nordisk-ousts-ceo-as-competition-weighs/
Instant View: Wegovy-maker Novo Nordisk ousts CEO as competition in obesity drug market heats up
reuters.com/business/healthcare-pharmaceuticals/view-wegovy-maker-novo-nordisk-ousts-ceo-competition-obesity-drug-market-heats-2025-05-16/
Novo ousts CEO Jorgensen after Lilly competition hits shares: Lars Fruergaard Jorgensen's departure follows a 53% decline in Novo Nordisk's share price over the ...
fortune.com/europe/2025/05/16/novo-ousts-ceo-jorgensen-lilly-competition-hits-shares/
Paid articlePaywall
Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year: Lars Fruergaard Jørgensen will leave after leading the drugmaker through ...
qz.com/novo-nordisk-ceo-resigns-stock-ozempic-wegovy-1851780983
Novo Nordisk Says CEO to Step Down: It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.
barrons.com/articles/novo-nordisk-ceo-steps-down-c1337f29
Paid articlePaywall
Novo Nordisk (NOVOB) CEO Jorgensen to Leave After Fall in Share Price: Novo Nordisk A/S is replacing Chief Executive Officer Lars Fruergaard Jorgensen as the ...
bloomberg.com/news/articles/2025-05-16/novo-nordisk-ceo-jorgensen-to-leave-after-fall-in-share-price
Paid articlePaywall Novo Nordisk: Eli Lilly beats the Danes: Eli Lilly's weight-loss injection Zepbound beats Novo Nordisk's Wegovy with 20.2% to 13.7% weight loss.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-eli-lilly-sticht-die-daenen-aus-20380241.html
Paid articlePaywall Novo Nordisk goes on the offensive - | but is that enough?: Novo Nordisk competes with Eli Lilly in the obesity | and diabetes market and relies on innovative ...
deraktionaer.de/artikel/deraktionaerplus/novo-nordisk-geht-in-die-offensive-doch-reicht-das-20380216.html
Paid articlePaywall Next